核向的声敏剂激活了cGAS-STING途径,用于瘤声动力免疫疗法
Jian Chen1, Zeyu Duan1, Qiyu Zhan1
1Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, PR China.
ACS applied bio materials
|November 6, 2024
概括
这项研究引入了TBzT-CPi,一种新型分子,通过向癌细胞核来增强声动疗 (SDT). 这种方法可以增强抗瘤免疫力,并触发癌细胞死亡,为癌症治疗提供了一种新的策略.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 核对于声动力学疗法 (SDT) 和抗瘤免疫非常重要.
- 在现场产生反应性氧物种 (ROS),损伤核,并激活cGAS-STING途径以产生免疫反应方面存在挑战.
研究的目的:
- 开发一种小分子,TBzT-CPi,可以放大核向SDT和cGAS-STING通路依赖的免疫刺激.
- 研究TBzT-CPi在诱导癌细胞死亡和调节瘤微环境方面的疗效.
主要方法:
- 设计了一个D-A-π-A1结构小分子,TBzT-CPi.
- 利用超声波辐射触发ROS生成和TBzT-CPi的核积累.
- 在瘤微环境中评估DNA损伤,免疫细胞死亡 (ICD),细胞亡和免疫细胞激活 (细胞毒性T淋巴细胞,树突细胞).
主要成果:
- 在超声波照射时,TBzT-CPi在核中积累,在现场产生ROS.
- 向核的SDT诱导了瘤细胞中的DNA损伤,亡和ICD.
- TBzT-CPi治疗通过激活免疫细胞和分泌细胞因子来改变免疫抑制瘤微环境.
结论:
- 用TBzT-CPi向核的SDT有效诱导癌细胞死亡并增强抗瘤免疫力.
- 这一战略显示出开发用于声动力免疫治疗的新型声敏化剂的前景.
- TBzT-CPi通过将直接杀死瘤细胞与免疫系统激活相结合,代表了癌症治疗的潜在治疗剂.
更多相关视频
09:05Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
Published on: July 22, 2015
11.1K
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
15.9K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
